Safety and biologic activity of a canine anti‐CD20 monoclonal antibody in dogs with diffuse large B‐cell lymphoma

Abstract Background To explore the safety and utility of combining low dose single‐agent doxorubicin with a canine specific anti‐CD20 monoclonal antibody (1E4‐cIgGB) in client owned dogs with untreated B‐cell lymphoma. Animals Forty‐two client‐owned dogs with untreated B‐cell lymphoma. Methods A pro...

Full description

Bibliographic Details

Published in:	Journal of Veterinary Internal Medicine
Main Authors:	Gretchen P. McLinden, Anne C. Avery, Heather L. Gardner, Kelly Hughes, Angie M. Rodday, Kexuan Liang, Cheryl A. London
Format:	Article
Language:	English
Published:	Wiley 2024-05-01
Subjects:	canine CD20 lymphoma monoclonal antibody veterinary
Online Access:	https://doi.org/10.1111/jvim.17080